Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson's disease

Tanja Stojkovic1,2, Elka Stefanova3,4, Ivan Soldatovic5,4

  • 1Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia. tanjili80@gmail.com.

Journal of Neurology
|March 25, 2018
PubMed
Abstract

Insights

Cognitive disorders are common in Parkinson's disease (PD), linked to motor deficits and vascular risk. Addressing vascular factors may offer preventive strategies for cognitive decline in PD patients.

Area of Science:

  • Neuroscience
  • Neurology
  • Geriatrics

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder with a high prevalence of cognitive impairment.
  • Cognitive disorders in PD significantly impact patient quality of life and disease progression.

Purpose of the Study:

  • To determine the frequency and types of cognitive disorders in a Parkinson's disease cohort.
  • To explore the relationship between cognitive impairment, motor symptoms, vascular risk factors, and white matter lesion (WML) volume in PD.

Main Methods:

  • A cross-sectional analysis of 133 Parkinson's disease patients was conducted.
  • Cognitive impairment was diagnosed using Movement Disorders Society Task Force criteria for mild cognitive impairment (PD-MCI) and dementia (PDD).
  • Motor symptoms, vascular risk (Framingham score), and white matter lesion (WML) volume were assessed.

Main Results:

  • 46.9% of patients had PD-MCI and 17.7% had PDD; non-amnestic multiple domain MCI was most frequent.
  • Cognitively impaired patients exhibited higher motor scores, particularly axial deficits.
  • High vascular risk and WML volume were associated with cognitive impairment, particularly PDD and specific deficits like FOG and attention.

Conclusions:

  • Cognitive disorders in PD are associated with more severe motor deficits, especially axial symptoms.
  • Increased vascular burden, a potentially modifiable factor, is linked to cognitive impairment in PD.
  • These findings suggest potential for developing preventive strategies targeting vascular health in Parkinson's disease.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...